PhoenixBio Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Public

  • Employees
  • 69

Employees

  • Stock Symbol
  • 6190

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $1.56
  • (As of Monday Closing)

PhoenixBio General Information

Description

PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics-related tests, safety tests, and hepatitis virus (HBV / HCV) related drug efficacy tests. Geographically, the company generates the majority of its revenue from USA.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 3-4-1 Kagamiyama
  • Higashihiroshima, Hiroshima 739-0046
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
TKS
Corporate Office
  • 3-4-1 Kagamiyama
  • Higashihiroshima, Hiroshima 739-0046
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PhoenixBio Stock Performance

As of 16-Nov-2026, PhoenixBio’s stock price is $1.56. Its current market cap is $6.36M with 4.07M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.56 $1.63 $1.49 - $4.10 $6.36M 4.07M 9.9K $0.02

PhoenixBio Financials Summary

As of 30-Jun-2026, PhoenixBio has a trailing 12-month revenue of $9.2M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 4,209 6,735 4,876 6,993
Revenue 9,224 10,387 10,108 11,872
EBITDA 1,065 (2,674) 567
Net Income 97 831 (2,944) 183
Total Assets 12,775 13,716 15,272 17,941
Total Debt 1,853 3,044 3,778 4,783
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PhoenixBio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PhoenixBio‘s full profile, request access.

Request a free trial

PhoenixBio Patents

PhoenixBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026141509-A1 Mouse hepatocyte gene regulated-type human liver model animal Pending 26-Dec-2024
WO-2026029135-A1 Amyloid β accumulation model animal Pending 01-Aug-2024
WO-2024204718-A1 Screening method for high specific gravity lipoprotein particle function promoter Inactive 31-Mar-2023
EP-4673530-A1 Role of hepatocyte-derived extracellular matrix and coagulation factors for the fate restoration and maintenance of human hepatocytes Pending 02-Mar-2023
US-20260242739-A1 Role of hepatocyte-derived extracellular matrix and coagulation factors for the fate restoration and maintenance of human hepatocytes Pending 02-Mar-2023 C12N5/067
To view PhoenixBio’s complete patent history, request access »

PhoenixBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PhoenixBio Acquisitions (1)

PhoenixBio’s most recent deal was a Merger/Acquisition with KMT Hepatech for . The deal was made on 01-Dec-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
KMT Hepatech 01-Dec-2017 Merger/Acquisition Other Healthcare Technology Systems
To view PhoenixBio’s complete acquisitions history, request access »

PhoenixBio ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Commercial Services

Industry

Rank

Percentile

Business Support Services

Subindustry

Rank

Percentile

To view PhoenixBio’s complete esg history, request access »

PhoenixBio Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
KMT Hepatech Edmonton, Canada 2001

PhoenixBio FAQs

  • When was PhoenixBio founded?

    PhoenixBio was founded in 2002.

  • Where is PhoenixBio headquartered?

    PhoenixBio is headquartered in Higashihiroshima, Japan.

  • What is the size of PhoenixBio?

    PhoenixBio has 69 total employees.

  • What industry is PhoenixBio in?

    PhoenixBio’s primary industry is Drug Discovery.

  • Is PhoenixBio a private or public company?

    PhoenixBio is a Public company.

  • What is PhoenixBio’s stock symbol?

    The ticker symbol for PhoenixBio is 6190.

  • What is the current stock price of PhoenixBio?

    As of 16-Nov-2026 the stock price of PhoenixBio is $1.56.

  • What is the current market cap of PhoenixBio?

    The current market capitalization of PhoenixBio is $6.36M.

  • What is PhoenixBio’s current revenue?

    The trailing twelve month revenue for PhoenixBio is $9.2M.

  • What is PhoenixBio’s annual earnings per share (EPS)?

    PhoenixBio’s EPS for 12 months was $0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process